首页> 外文期刊>BMC Immunology >Immune analysis of expression of IL-17 relative ligands and their receptors in bladder cancer: comparison with polyp and cystitis
【24h】

Immune analysis of expression of IL-17 relative ligands and their receptors in bladder cancer: comparison with polyp and cystitis

机译:膀胱癌中IL-17相对配体及其受体表达的免疫分析:与息肉和膀胱炎的比较

获取原文
           

摘要

Background Bladder cancer, cystitis and bladder polyp are the most common urinary system diseases all over the world. Our former research results show that IL-17A and IL-17?F contribute to the pathogenesis of benign prostatic hyperplasia (BPH) and prostate cancer (Pca) while IL-17E interacting with IL-17RB might have an anti-tumor effect. Results Using imunohistochemistry, we systemically compared immunoreactivity of ligands (IL-17A, E and F) and receptors (IL-17RA, IL-17RB and IL-17RC) of IL-17 family, infiltration of inflammatory cells and changes of structural cells (fibroblast cells, smooth muscle and vascular endothelial cells) in sections of bladder tissues from subjects with bladder cancer, cystitis and bladder polyp. Compared with subjects with cystitis, immunoreactivity for IL-17A, IL-17?F and IL-17RC was significantly elevated in the group of bladder cancer ( p + blood vessels and immunoreactivity of CD90+ fibroblasts were also elevated in patients with bladder cancer compared with those of cystitis. The patterns of IL-17 ligands and receptors, and inflammatory cells and structural cells varied in cystitis, bladder polyp and bladder cancer. In bladder cancer, immunoreactivity of IL-17E and IL-17?F was positively correlated with smooth muscles and lymphocytes, respectively. In addition, immunoreactivity of IL-17A and IL-17E was positively correlated with their receptors IL-17RA and IL-17RB respectively. Conclusions The data suggest that changed patterns of expression of the IL-17 cytokine family ligands and receptors might be associated with infiltration of inflammatory cells and structural cells (CD90+ fibroblasts and CD31+ blood vessels), which might also contribute to occurrence and development in bladder cancer.
机译:背景技术膀胱癌,膀胱炎和膀胱息肉是全世界最常见的泌尿系统疾病。我们以前的研究结果表明,IL-17A和IL-17?F有助于良性前列腺增生(BPH)和前列腺癌(Pca)的发病,而IL-17E与IL-17RB相互作用可能具有抗肿瘤作用。结果我们使用免疫组织化学系统地比较了IL-17家族的配体(IL-17A,E和F)和受体(IL-17RA,IL-17RB和IL-17RC)的免疫反应性,炎性细胞的浸润和结构细胞的变化(患有膀胱癌,膀胱炎和膀胱息肉的受试者的膀胱组织切片中的成纤维细胞,平滑肌和血管内皮细胞)。与膀胱炎患者相比,膀胱癌组(p + 血管和CD90 + 与膀胱炎相比,膀胱癌患者中的成纤维细胞也升高;在膀胱炎,膀胱息肉和膀胱癌中,IL-17配体和受体的模式以及炎性细胞和结构性细胞有所不同。结论17E和IL-17?F分别与平滑肌和淋巴细胞呈正相关,并且IL-17A和IL-17E的免疫反应性与它们的受体IL-17RA和IL-17RB呈正相关。 IL-17细胞因子家族配体和受体表达模式的改变可能与炎症细胞和结构细胞(CD90 + 成纤维细胞和CD31 + 血管)的浸润有关,这也可能归因于膀胱癌的发生和发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号